Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1938-1945

  Wegorzewska, Marta ^a,b   Nijagal, Amar ^a,b   Wong, Charissa M ^a,b   Le, Tom ^a,b   Lescano, Ninnia ^a,b   Tang, Qizhi ^b   MacKenzie, Tippi C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GAMMA INTERFERON;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FETAL THERAPY; FETUS; FETUS DEATH; FETUS WASTAGE; HEMATOPOIETIC CELL; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UTERUS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD4; CYTOKINES; FEMALE; FETAL THERAPIES; FETUS; HISTOCOMPATIBILITY, MATERNAL-FETAL; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; PREGNANCY; PREGNANCY COMPLICATIONS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; UTERUS;

EID: 84896735954     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302403     Document Type: Article

References (43)

1. Adzick, N. S. 2010. Open fetal surgery for life-threatening fetal anomalies. Semin. Fetal Neonatal Med. 15: 1-8.
2. Nijagal, A., A. W. Flake, and T. C. MacKenzie. 2012. In utero hematopoietic cell transplantation for the treatment of congenital anomalies. Clin. Perinatol. 39: 301-310.
3. Golombeck, K., R. H. Ball, H. Lee, J. A. Farrell, D. L. Farmer, V. R. Jacobs, M. A. Rosen, R. A. Filly, and M. R. Harrison. 2006. Maternal morbidity after maternal-fetal surgery. Am. J. Obstet. Gynecol. 194: 834-839.
4. Adzick, N. S., E. A. Thom, C. Y. Spong, J. W. Brock, III, P. K. Burrows, M. P. Johnson, L. J. Howell, J. A. Farrell, M. E. Dabrowiak, L. N. Sutton, et al. 2011. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N. Engl. J. Med. 364: 993-1004.
5. Harrison, M. R., R. L. Keller, S. B. Hawgood, J. A. Kitterman, P. L. Sandberg, D. L. Farmer, H. Lee, R. A. Filly, J. A. Farrell, and C. T. Albanese. 2003. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N. Engl. J. Med. 349: 1916-1924.
6. Erlebacher, A. 2013. Immunology of the maternal-fetal interface. Annu. Rev. Immunol. 31: 387-411.
7. Munoz-Suano, A., A. B. Hamilton, and A. G. Betz. 2011. Gimme shelter: the immune system during pregnancy. Immunol. Rev. 241: 20-38.
8. Zenclussen, A. C. 2013. Adaptive immune responses during pregnancy. Am. J. Reprod. Immunol. 69: 291-303.
9. Erlebacher, A. 2013. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat. Rev. Immunol. 13: 23-33.
10. Erlebacher, A., D. Vencato, K. A. Price, D. Zhang, and L. H. Glimcher. 2007. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J. Clin. Invest. 117: 1399-1411.
11. Suchin, E. J., P. B. Langmuir, E. Palmer, M. H. Sayegh, A. D. Wells, and L. A. Turka. 2001. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166: 973-981.
12. Aluvihare, V. R., M. Kallikourdis, and A. G. Betz. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5: 266-271.
13. + regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol. Lett. 102: 106-109.
14. Kahn, D. A., and D. Baltimore. 2010. Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc. Natl. Acad. Sci. USA 107: 9299-9304.
15. + regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe 10: 54-64.
16. Rowe, J. H., J. M. Ertelt, L. Xin, and S. S. Way. 2012. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490: 102-106.
17. Samstein, R. M., S. Z. Josefowicz, A. Arvey, P. M. Treuting, and A. Y. Rudensky. 2012. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150: 29-38.
18. Shima, T., Y. Sasaki, M. Itoh, A. Nakashima, N. Ishii, K. Sugamura, and S. Saito. 2010. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J. Reprod. Immunol. 85: 121-129.
19. + regulatory T cell pool during pregnancy. J. Reprod. Immunol. 75: 71-81.
20. Guleria, I., A. Khosroshahi, M. J. Ansari, A. Habicht, M. Azuma, H. Yagita, R. J. Noelle, A. Coyle, A. L. Mellor, S. J. Khoury, and M. H. Sayegh. 2005. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med. 202: 231-237.
21. Munn, D. H., M. Zhou, J. T. Attwood, I. Bondarev, S. J. Conway, B. Marshall, C. Brown, and A. L. Mellor. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193.
22. Nijagal, A., M. Wegorzewska, E. Jarvis, T. Le, Q. Tang, and T. C. MacKenzie. 2011. Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice. J. Clin. Invest. 121: 582-592.
23. Nijagal, A., T. Le, M. Wegorzewska, and T. C. Mackenzie. 2011. A mouse model of in utero transplantation. J. Vis. Exp. pii: 2303.
24. Elovitz, M. A., Z. Wang, E. K. Chien, D. F. Rychlik, and M. Phillippe. 2003. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am. J. Pathol. 163: 2103-2111.
25. Koch, M. A., G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, and D. J. Campbell. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10: 595-602.
26. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
27. + T-cell receptor transgenic T cells alone can reject vascularized heart transplants through the indirect pathway of alloantigen recognition. Transplantation 77: 452-455.
28. Madeja, Z., H. Yadi, R. Apps, S. Boulenouar, S. J. Roper, L. Gardner, A. Moffett, F. Colucci, and M. Hemberger. 2011. Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc. Natl. Acad. Sci. USA 108: 4012-4017.
29. Nancy, P., E. Tagliani, C. S. Tay, P. Asp, D. E. Levy, and A. Erlebacher. 2012. Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 336: 1317-1321.
30. + direct pathway: level of priming determines acute versus chronic rejection. Transplantation 85: 247-255.
31. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335: 271-274.
32. Dakic, A., Q. X. Shao, A. D'Amico, M. O'Keeffe, W. F. Chen, K. Shortman, and L. Wu. 2004. Development of the dendritic cell system during mouse ontogeny. J. Immunol. 172: 1018-1027.
33. Muthukkumar, S., J. Goldstein, and K. E. Stein. 2000. The ability of B cells and dendritic cells to present antigen increases during ontogeny. J. Immunol. 165: 4803-4813.
34. Collins, M. K., C. S. Tay, and A. Erlebacher. 2009. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J. Clin. Invest. 119: 2062-2073.
35. Saadai, P., T. H. Lee, G. Bautista, K. D. Gonzales, A. Nijagal, M. P. Busch, C. J. Kim, R. Romero, H. Lee, S. Hirose, et al. 2012. Alterations in maternalfetal cellular trafficking after fetal surgery. J. Pediatr. Surg. 47: 1089-1094.
36. + regulatory T cell-sustained fetal tolerance. PLoS Pathog. 8: e1002873.
37. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
38. DiGiulio, D. B., R. Romero, J. P. Kusanovic, R. Gómez, C. J. Kim, K. S. Seok, F. Gotsch, S. Mazaki-Tovi, E. Vaisbuch, K. Sanders, et al. 2010. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am. J. Reprod. Immunol. 64: 38-57.
39. Tilburgs, T., S. A. Scherjon, B. J. van der Mast, G. W. Haasnoot, M. Versteeg-V D Voort-Maarschalk, D. L. Roelen, J. J. van Rood, and F. H. Claas. 2009. Fetalmaternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J. Reprod. Immunol. 82: 148-157.
40. + effector-memory T cells with unique properties. J. Immunol. 185: 4470-4477.
41. Redline, R. W., and P. Patterson. 1993. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am. J. Pathol. 143: 473-479.
42. Myerson, D., R. K. Parkin, K. Benirschke, C. N. Tschetter, and S. R. Hyde. 2006. The pathogenesis of villitis of unknown etiology: analysis with a new conjoint immunohistochemistry-in situ hybridization procedure to identify specific maternal and fetal cells. Pediatr. Dev. Pathol. 9: 257-265.
43. Kim, M. J., R. Romero, C. J. Kim, A. L. Tarca, S. Chhauy, C. LaJeunesse, D. C. Lee, S. Draghici, F. Gotsch, J. P. Kusanovic, et al. 2009. Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J. Immunol. 182: 3919-3927.